抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體
Anti-Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Monoclonal Antibody
FH3; HCHOLA3; NARC1; Hypercholesterolemia,Autosomal Dominant 3; Neural apoptosis-regulated convertase 1; Proprotein convertase 9; Subtilisin/kexin-like protease PC9
- 編號(hào)FAE189Ra02
- 物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
- 效價(jià)-
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無(wú)標(biāo)記物
- 激發(fā)波長(zhǎng)
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 且適物種-
- 應(yīng)用Flow cytometry.
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價(jià)格 暫無(wú)報(bào)價(jià) 暫無(wú)報(bào)價(jià) 暫無(wú)報(bào)價(jià) 暫無(wú)報(bào)價(jià) 暫無(wú)報(bào)價(jià)
- 欲了解實(shí)際交易價(jià)格和更多情況,請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
編號(hào) | 適用物種:Rattus norvegicus (Rat,大鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
RPE189Ra01 | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAE189Ra01 | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)多克隆抗體 | WB; IHC; ICC; IP. |
MAE189Ra23 | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體 | WB; IHC; ICC; IP. |
MAE189Ra22 | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體 | WB; IHC; ICC; IP. |
MAE189Ra21 | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體 | WB; IHC |
FAE189Ra02 | 抗前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)單克隆抗體 | Flow cytometry. |
SEE189Ra | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LME189Ra | 前蛋白轉(zhuǎn)化酶枯草溶菌素9(PCSK9)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
雜志 | 參考文獻(xiàn) |
Biological Trace Element Research | Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers [pubmed:28409410] |
BASIC RESEARCH IN CARDIOLOGY | Autocrine effects of PCSK9 on cardiomyocytes [Pubmed: 33169229] |
J Transl Med | Multi-omic signatures of atherogenic dyslipidaemia: pre-clinical target identification and validation in humans [33407555] |
Metabolism | MiR-337-3p lowers serum LDL-C level through targeting PCSK9 in hyperlipidemic mice [33775647] |
Eur Rev Med Pharmacol Sci | Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders [34533801] |
Clin Exp Hypertens | Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease [Pubmed:35502687] |
留言咨詢